Cite
HARVARD Citation
Habra, M. et al. (2019). Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma. Journal for immunotherapy of cancer. 7 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Habra, M. et al. (2019). Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma. Journal for immunotherapy of cancer. 7 (1), p. . [Online].